Boston Scientific launches a clinical trial of its Vessix renal denervation device in treating hypertension, aiming to separate its effects from drug therapy for high blood pressure.
ReCor Medical raises a $15 million Series D financing for a planned U.S. study of its ultrasound renal denervation device.
A Japanese healthcare conglomerate is the lead investor ReCor Medical's $15 million Series D round ReCor plans to use to back a U.S. clinical trial of its ultrasound renal denervation device.
Baxter International wins CE Mark approval in the European Union for its HomeChoice Claria device for home peritoneal dialysis treatments.
Medtronic launches a new clinical trial examining renal denervation as a treatment for hypertension, aiming to settle the 'confounding factors' that led to the failure of its Symplicity-3 trial.
Osprey Medical says it raised a private placement worth about $11 million for its Avert device to prevent contrast-induced nephropathy.
Surgeons in San Francisco begin a 6-way kidney transplant chain involving 12 patients that began with a single altruistic donor.
(Reuters) — Doctors at a San Francisco hospital began an unusual series of kidney transplants yesterday with 6 living donors providing organs to 6 patients in a chain that began with a woman described as an altruistic donor unrelated to any of the recipients.
Medtronic is taking another shot at renal denervation to treat drug-resistant hypertension, a year after a pivotal trial for its key product in the space failed to meet its efficacy endpoint.